3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Stomach Neoplasms
1
Malnutrition
1
Hyperphagia
1
Esophageal Neoplasms
1
Interventions
Oxaliplatin
300
Fluorouracil
272
Bevacizumab
237
Gemcitabine
236
Leucovorin
212
Capecitabine
207
pembrolizumab
201
Nivolumab
158
Irinotecan
158
Cisplatin
150
Specimen Handling
144
Magnetic Resonance Spectroscopy
130
130-nm albumin-bound paclitaxel
118
Paclitaxel
109
durvalumab
107
Cetuximab
104
Radiotherapy
99
atezolizumab
94
Drug Therapy
94
Biopsy
93
tislelizumab
81
Albumin-Bound Paclitaxel
81
Taxes
74
Folfox protocol
68
lenvatinib
67
Carboplatin
66
regorafenib
60
Blood Specimen Collection
60
sintilimab
54
Ipilimumab
53
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Parenteral Nutrition
×
Gastrointestinal
×
1 year
×
Clear all
NCT07604857
2026-05-22
BRIDGE-GC
The Catholic University of Korea
Phase NA
Completed
55 enrolled
NCT07584577
2026-05-13
FREJENO
University Hospital, Bordeaux
Recruiting
670 enrolled